Coordinated follow-up Breast Cancer Survivorship Care Program study.

e17727 Background: Previous research has demonstrated that cancer survivors often fail to receive recommended care, but also often receive redundant or unnecessary care, reducing care quality and increasing costs. Methods: This phase II trial randomized 100 stage 0-IIIa breast cancer pts who had primary care providers within our hospital network (with accessible online records), and seen at Dana-Farber/Faulkner medical oncology, to either Coordinated Follow-Up Care = CC (entailing a patient navigator calling every 3 months, a tailored survivorship care plan, and a follow-up care algorithm aimed to reduce redundant care) or standard care = SC for one year after completion of last active treatment (chemotherapy, surgery, or radiation) to assess whether the CC made subsequent medical care more efficient. The 1° endpoint was frequency of redundant exams ( > 1 breast/chest wall exam per pt within any 30 day period in the absence of a new breast/chest wall complaint over the year of follow-up); a secondary endp...